Stocks and Investing Stocks and Investing
Thu, November 2, 2017
[ 12:00 AM ] - WOPRAI
Manav Patnaik Maintained (VRSK) at Buy with Increased Target to $105 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Anjaneya Singh Maintained (VRSK) at Hold with Increased Target to $92 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (AXGN) at Buy with Increased Target to $26 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Jason Mills Maintained (ATRC) at Strong Buy with Decreased Target to $24 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Glenn Greene Maintained (WEX) at Buy with Increased Target to $130 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Darrin Peller Maintained (WEX) at Hold with Increased Target to $129 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Danyal Hussain Maintained (WEX) at Hold with Increased Target to $123 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Christopher Tillett Maintained (WES) at Buy with Decreased Target to $62 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Tom Abrams Maintained (WES) at Hold with Decreased Target to $52 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Alvin Concepcion Maintained (WBA) at Strong Buy with Decreased Target to $81 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Mark Jarvi Downgraded (BEP) to Hold on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (BFAM) at Hold with Increased Target to $90 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Anjaneya Singh Maintained (BFAM) at Hold with Increased Target to $90 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Sheryl Skolnick Upgraded (AMED) to Strong Buy on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Bill Sutherland Upgraded (AMED) to Strong Buy on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Ryan Tunis Maintained (ALL) at Hold with Increased Target to $95 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Rahul Jasuja Maintained (ALNY) at Strong Buy with Increased Target to $240 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Timothy Thein Maintained (ALSN) at Strong Buy with Increased Target to $50 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Maintained (ZBH) at Buy with Decreased Target to $135 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (ZBH) at Buy with Decreased Target to $136 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Ole Slorer Maintained (ASC) at Hold with Increased Target to $9 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
William Katz Maintained (APO) at Strong Buy with Increased Target to $38 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Craig Siegenthaler Maintained (APO) at Hold with Increased Target to $35 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Craig Schmidt Downgraded (AAT) to Hold on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
A.J. Rice Initiated (ACHC) at Hold and Held Target at $35 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Mark Kalinowski Maintained (CAKE) at Hold with Decreased Target to $40 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (CAKE) at Hold with Decreased Target to $43 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
John Glass Maintained (CAKE) at Hold with Decreased Target to $44 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Lynne Collier Maintained (CAKE) at Hold with Decreased Target to $48 on, Nov 2nd, 2017
[ 12:00 AM ] - WOPRAI
Alethia Young Maintained (AGIO) at Buy with Increased Target to $66 on, Nov 2nd, 2017

Alethia Young Maintained (AGIO) at Buy with Increased Target to $66 on, Nov 2nd, 2017


Published on 2024-10-26 00:22:46 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $61 to $66 on, Nov 2nd, 2017.

Alethia has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 0 agree with Alethia's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Alethia

  • Kennen MacKay of "RBC Capital" Initiated at Buy and Held Target at $78 on, Friday, September 15th, 2017
  • Michael Schmidt of "Leerink Swann" Upgraded from Hold to Buy on, Wednesday, August 2nd, 2017
Contributing Sources